Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS (Details)

v3.23.3
ACQUISITIONS (Details) - USD ($)
$ in Thousands
 1 Months Ended
Sep. 30, 2021
Sep. 30, 2023
Dec. 31, 2022
Business Acquisition [Line Items]      
Contingent consideration liabilities - current portion   $ 1,617 $ 3,398
Nature's Remedy      
Business Acquisition [Line Items]      
Contingent consideration, equity interest issued and issuable $ 5,000    
Contingent consideration, liability, monthly earnout 278    
Contingent consideration, liability, earnout calculation, ratio to share price $ 1,667    
Contingent liability   1,617 4,793
Contingent consideration liabilities - current portion   $ 3,333 3,398
Other liabilities - non-current     $ 1,395
Nature's Remedy | Milestone Period One      
Business Acquisition [Line Items]      
Contingent consideration period 12 months    
Nature's Remedy | Milestone Period Two      
Business Acquisition [Line Items]      
Contingent consideration period 30 months    
Nature's Remedy | Monthly Milestone Period One      
Business Acquisition [Line Items]      
Contingent consideration period 18 months    
Nature's Remedy | Monthly Milestone Period Two      
Business Acquisition [Line Items]      
Contingent consideration period 24 months    
Nature's Remedy | Monthly Milestone Period Three      
Business Acquisition [Line Items]      
Contingent consideration period 30 months